Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06313606 · ClinicalTrials.gov registry record · NA
Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ
A NA study of Dietary Fat Metabolism, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06313606 is a NA study of Dietary Fat Metabolism that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06313606, a NA study of Dietary Fat Metabolism, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Long-chain cyclopropane fatty acids (CpFAs) are microbially-derived lipids (fats), some of which can be found in select foods and appear to be produced naturally in the gut from dietary fatty acid precursors. Some of these lipids appear to have signaling properties in the body's tissues, i.e., to help regulate cardiometabolic health. Thus, increasing the bioavailability of CpFAs in humans may have utility to improve management of blood sugar and blood lipids, or to mitigate or prevent non-alcoholic fatty liver disease (NAFLD). This study is a proof-of-principle experiment in 10 subjects, to feed dietary fats thought to enhance upper gut CpFA production. The latter will be monitored through post-meal blood and urine CpFA concentration measurements, as well as concentration in the stool.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary fat positive control
- DIETARY_SUPPLEMENT Dietary fat negative control
Study Locations (1)
California
- University of California, Davis School of Medicine - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06313606
The ClinicalTrials.gov registry entry for NCT06313606 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dietary Fat Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Dietary fat positive control is the first listed.
NCT06313606 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06313606 about?
NCT06313606 is a clinical study titled "Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ". Long-chain cyclopropane fatty acids (CpFAs) are microbially-derived lipids (fats), some of which can be found in select foods and appear to be produced naturally in the gut from dietary fatty acid precursors. Some of these lipids appear to have signaling properties in the body's tissues, i.e., to he...
What is the current status of trial NCT06313606?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-04-01. Estimated completion is 2025-05-31.
What conditions does trial NCT06313606 study?
This clinical trial studies the following conditions: Dietary Fat Metabolism.
What interventions are being tested in trial NCT06313606?
The interventions under investigation include: Dietary fat positive control (DIETARY_SUPPLEMENT), Dietary fat negative control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06313606?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06313606 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.